Advertisement

Reactions Weekly

, Volume 1658, Issue 1, pp 185–185 | Cite as

Erlotinib

Development of erlotinib resistance in non small cell lung cancer followed by disease progression and dermatotoxicity: case report
Case report
  • 22 Downloads

Reference

  1. Faehling M, et al. Molecular profiling of EGFR-positive NSCLC with secondary T790M resistance mutation and tertiary transformation into small-cell lung cancer. Journal of Thoracic Oncology : S1259 abstr. P3.02b-109, Jan 2017 [abstract] -GermanyGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations